Alnylam Pharmaceuticals
ALNY
#649
Rank
S$50.32 B
Marketcap
S$376.90
Share price
-0.61%
Change (1 day)
-9.41%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company